SMTL ID : 6nna.1 (1 other biounit)

Human Fatty Acid Synthase Psi/KR Tri-Domain with NADPH and Compound 22

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.26 Å

Oligo State

monomer

Ligands

1 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NDP.1: 28 residues within 4Å: Chain A: G.431, G.434, G.435, F.436, T.455, S.456, R.457, S.458, N.485, S.487, L.511, A.512, V.513, V.514, P.534, K.535, F.559, S.560, S.561, Y.574, W.600, G.601, A.602, I.603, G.607, I.608, L.609 Ligands: KUA.2 25 PLIP interactions: 25 interactions with chain A Hydrophobic interactions: A:W.600, A:I.603 Hydrogen bonds: A:G.431, A:G.435, A:F.436, A:T.455, A:R.457, A:S.458, A:N.485, A:N.485, A:L.511, A:V.513, A:K.535, A:Y.574, A:I.603, A:I.608, A:L.609 Water bridges: A:G.434, A:G.437, A:R.461, A:R.461, A:I.486, A:S.487, A:G.607 Salt bridges: A:R.457

1 x KUA: {4-[4-(1,3-benzoxazol-2-yl)benzene-1-carbonyl]piperazin-1-yl}(1-hydroxycyclopropyl)methanone(Non-covalent)

KUA.2: 18 residues within 4Å: Chain A: H.155, P.156, L.515, S.561, V.562, S.563, R.566, N.568, Q.571, Y.574, A.602, I.608, L.609, V.620, S.621, T.623, F.649 Ligands: NDP.1 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:P.156, A:V.562, A:R.566, A:R.566, A:I.608, A:I.608, A:V.620, A:T.623 Hydrogen bonds: A:S.561, A:N.568, A:Q.571, A:Q.571 pi-Stacking: A:H.155, A:F.649

7 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 3 residues within 4Å: Chain A: R.457, T.483, N.485 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:T.483, A:N.485 EDO.4: 6 residues within 4Å: Chain A: T.12, E.16, P.114, A.115, A.118, F.409 1 PLIP interactions: 1 interactions with chain A Water bridges: A:T.12 EDO.5: 4 residues within 4Å: Chain A: P.128, K.131, D.203, R.229 No protein-ligand interaction detected (PLIP) EDO.6: 7 residues within 4Å: Chain A: N.126, M.127, P.128, R.296, R.353, N.359, R.362 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.296, A:R.353 EDO.7: 7 residues within 4Å: Chain A: E.7, K.117, P.154, H.155, H.408, R.566, F.649 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:E.7, A:K.117, A:P.154, A:R.566 EDO.8: 6 residues within 4Å: Chain A: H.14, T.15, L.280, V.281, G.282, L.283 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:H.14, A:T.15 EDO.9: 6 residues within 4Å: Chain A: I.338, N.339, C.340, L.366, S.367, N.368 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.339, A:N.368 Water bridges: A:C.340, A:A.341

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Martin, M.W. et al., Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN). Bioorg. Med. Chem. Lett. (2019)

Release Date

2019-02-20

Peptides

Fatty acid synthase,Fatty acid synthase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fatty acid synthase,Fatty acid synthase

Related Entries With Identical Sequence